Patents by Inventor Kooji Kagara

Kooji Kagara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6455726
    Abstract: A compound of the following formula (II) and a process for preparing of the compound of the following formula (I) its preparation wherein R1 is carboxy or protected carboxy; R2 is lower alkoxy or higher alkoxy; A1 is a divalent aromatic ring, a divalent heterocyclic group or a divalent cyclo(lower)alkane; and A2 is a divalent aromatic ring, a divalent heterocyclic group or a divalent cyclo(lower)alkane, or a salt thereof. The process comprises, reacting a compound of the formula (III): wherein R1, R2, A1 and A2 are each as defined above or a salt thereof, with an acid ammonium salt to give a compound of the formula (II).
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: September 24, 2002
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Masaharu Ichihara, Norio Hashimoto, Atsushi Kanda, Kooji Kagara
  • Patent number: 6355800
    Abstract: A new industrial process excellent in yield and purity for preparing a compound of the formula: or a salt thereof in a less number of steps with a synthetic pathway without proceeding via nitroso compounds, wherein R1 is lower aryl, ar(lower)alkoxy or heterocyclic group, each of which may be substituted with halogen, and R2 is cyclo(lower)alkyl, aryl or ar(lower)alkyl, each of which may be substituted with halogen.
    Type: Grant
    Filed: April 6, 2000
    Date of Patent: March 12, 2002
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Kooji Kagara, Norio Hashimoto, Atsushi Kanda, Yukihisa Baba, Tetsuo Furutera
  • Patent number: 6344559
    Abstract: This invention provides an industrially useful process for producing a quinazoline derivative (I) of the general formula: [wherein R1 is hydrogen or halogen; R2 is carboxy or protected carboxy; A is lower alkylene] or its salt on a commercial scale which comprises reacting a compound of the general formula: [wherein R1 is hydrogen or halogen] or its salt with a silylating agent and then with a compound of the general formula: Cl—A—R2  (III) [wherein R2 is carboxy or protected carboxy; A is lower alkylene] or its salt, optionally followed by desilylation.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: February 5, 2002
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Hiroki Omori, Shunsuke Goto, Hiroyuki Tsuboi, Masayasu Fukagawa, Kooji Kagara
  • Patent number: 6291680
    Abstract: A compound of formula (1) or a salt thereof: wherein R1 is a carboxy or a protected carboxy; R2 is a lower alkoxy or a higher alkoxy; A1 is a divalent aromatic ring, a divalent heterocyclic group or a divalent cyclo(lower)alkane; and A2 a divalent aromatic ring, a divalent heterocyclic group or a divalent cyclo(lower)alkane; is prepared by reacting a compound of formula (III) or a salt thereof with acid ammonium salt: wherein R1, R2, A1 and A2 are each as defined above; to give a compound of formula (II) or a salt thereof which is further reacted with a salt of hydroxylamine: wherein R1, R2, A1 and A2 are each as defined above.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: September 18, 2001
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Masaharu Ichihara, Norio Hashimoto, Atsushi Kanda, Kooji Kagara
  • Publication number: 20010008943
    Abstract: The present invention relates to a novel process for preparing of the compound of the following formula (I)
    Type: Application
    Filed: February 14, 2001
    Publication date: July 19, 2001
    Applicant: FUJISAWA PHARMACEUTICAL CO., LTD.
    Inventors: Masaharu Ichihara, Norio Hashimoto, Atsushi Kanda, Kooji Kagara
  • Patent number: 6013653
    Abstract: A process for producing pyridiondole derivatives represented by general formula (III) or their salts (wherein R.sup.1 represents hydrogen, lower alkyl or lower alkenyl; R.sup.2 represents hydrogen, lower alkyl or halogeno; and R.sup.3 represents optionally substituted imidazolyl), which comprises reacting a compound represented by general formula (I) or its salt (wherein R.sup.1 and R.sup.2 are each as defined above) with a compound represented by general formula (II) or its salt (wherein R.sup.3.sub.a represents optionally substituted imidazolyl having an imino protecting group; and X represents halogeno), followed by a reaction for eliminating the imino protecting group); and a process for producing optically active pyridoindole derivatives represented by general formula (IV) or their salts: which comprises reacting a racemic mixture of the pyridoindole derivative represent by formula (III) or its salt with (1R)-(-)-10-camphorsulfonic acid.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: January 11, 2000
    Assignee: Fujisawa Pharmaceuticals Co., Ltd.
    Inventors: Kooji Kagara, Nobutaka Kawai, Takashi Nakamura, Shigeru Ieda, Koji Machiya, Atsushi Ohigashi
  • Patent number: 5523410
    Abstract: The present invention relates to synthetic intermediates useful for preparing amino acid derivatives possessing renin-inhibitory activity, and to processes for preparing the amino acid derivatives using the synthetic intermediates.
    Type: Grant
    Filed: January 3, 1995
    Date of Patent: June 4, 1996
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Kooji Kagara, Nobutaka Kawai, Koji Machiya, Tetsuo Furutera, Takashi Nakamura, Hiroki Omori
  • Patent number: 5254733
    Abstract: The present invention relates to a process for producing (.+-.)-(E)-4-ethyl-2-[E-hydroxyimino]-5-nitro-3-hexenamide.
    Type: Grant
    Filed: October 15, 1991
    Date of Patent: October 19, 1993
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Kooji Kagara, Nobutaka Kawai, Koji Machiya, Kiyoaki Takasuka